Dr Karen Pinilla is a clinical research fellow at the Cancer Research UK Cambridge Centre. She worked as a clinician in the breast unit at Addenbrooke’s Hospital before starting her fellowship in October 2019. She is now based in both Addenbrooke’s Hospital and the Cancer Research UK Cambridge Institute.
A major international study of the genetics of breast cancer has identified more than 350 DNA ‘errors’ that increase an individual’s risk of developing the disease. ̽»¨Ö±²¥scientists involved say these errors may influence as many as 190 genes.
Our immune systems are meant to keep us healthy, but sometimes they turn their fire on us, with devastating results. Immunotherapies can help defend against this ‘friendly fire’ – and even weaponise it in our defence.
A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy – a new approach to treating cancer by boosting a patient’s immune system – may fail in a substantial number of patients.Â
An international study of almost 120,000 women has newly identified five genetic variants affecting risk of breast cancer, all of which are believed to influence how breast cells respond to the female sex hormone oestrogen.
Launched today (26 September), Cancer Core Europe brings together six cancer centres – including the Cambridge Cancer Centre at the ̽»¨Ö±²¥ of Cambridge – to link cancer research through to cancer care.
Men who eat over 10 portions a week of tomatoes have an 18 per cent lower risk of developing prostate cancer, new research suggests.
Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.
Researchers have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse.
Computational biology is helping scientists to navigate through the data deluge generated from the analysis of cancer genomes.
© 2025 ̽»¨Ö±²¥ of Cambridge